FI94591C - Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi - Google Patents

Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi Download PDF

Info

Publication number
FI94591C
FI94591C FI891145A FI891145A FI94591C FI 94591 C FI94591 C FI 94591C FI 891145 A FI891145 A FI 891145A FI 891145 A FI891145 A FI 891145A FI 94591 C FI94591 C FI 94591C
Authority
FI
Finland
Prior art keywords
lysine
acid
active ingredients
fatty acids
dha
Prior art date
Application number
FI891145A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI891145A0 (fi
FI94591B (fi
FI891145A (fi
Inventor
Ti Nagy P Ter Liter
M Ria Boros
Jenoe Szilbereky
Cz Istv N R
Gyoengyv R Soos
Miklos Koller
R Al N Pint
Meth G Bor N
Original Assignee
Biorex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kft filed Critical Biorex Kft
Publication of FI891145A0 publication Critical patent/FI891145A0/fi
Publication of FI891145A publication Critical patent/FI891145A/fi
Publication of FI94591B publication Critical patent/FI94591B/fi
Application granted granted Critical
Publication of FI94591C publication Critical patent/FI94591C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI891145A 1988-03-09 1989-03-09 Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi FI94591C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU113288 1988-03-09
HU881132A HU209973B (en) 1988-03-09 1988-03-09 Process for production of antiviral and immunstimular pharmaceutical composition

Publications (4)

Publication Number Publication Date
FI891145A0 FI891145A0 (fi) 1989-03-09
FI891145A FI891145A (fi) 1989-09-10
FI94591B FI94591B (fi) 1995-06-30
FI94591C true FI94591C (fi) 1995-10-10

Family

ID=10952974

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891145A FI94591C (fi) 1988-03-09 1989-03-09 Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi

Country Status (14)

Country Link
JP (1) JPH01316316A (de)
KR (1) KR890014103A (de)
BE (1) BE1002890A3 (de)
CA (1) CA1334576C (de)
CH (1) CH678918A5 (de)
DE (1) DE3907649C2 (de)
FI (1) FI94591C (de)
FR (1) FR2628324B1 (de)
GB (1) GB2216418B (de)
HU (1) HU209973B (de)
IT (1) IT1229562B (de)
LU (1) LU87471A1 (de)
NL (1) NL8900574A (de)
SE (1) SE8900828L (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
JPH04279523A (ja) * 1991-01-11 1992-10-05 Nisshin Flour Milling Co Ltd 免疫賦活油脂加工品
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
CA2159116A1 (en) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5767156A (en) * 1993-10-06 1998-06-16 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
US5639858A (en) * 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
WO1996030381A1 (en) * 1995-03-28 1996-10-03 Novo Nordisk A/S Immunosuppressive agents
HU227588B1 (hu) 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
CA2709579A1 (en) * 2007-12-17 2009-06-25 University Of Florida Research Foundation, Inc. Materials and methods for treatment of pathological ocular vascular proliferation
FR3031451B1 (fr) * 2015-01-13 2018-03-23 Greentech Sel d'un triglyceride, preparation et utilisations
WO2017202942A1 (en) * 2016-05-25 2017-11-30 Evonik Technochemie Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
EP3248467A1 (de) 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
WO2019008101A1 (en) 2017-07-06 2019-01-10 Evonik Technochemie Gmbh ENTERICALLY COATED SOLID DOSAGE FORM COMPRISING AMINO ACIDS SALTS OF OMEGA-3 FATTY ACIDS
US11622952B2 (en) 2017-08-15 2023-04-11 Evonik Operations Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
BR112022002129A2 (pt) 2019-08-08 2022-04-19 Evonik Operations Gmbh Processo a jusante para a produção de sais de ácidos graxos poli-insaturados
US20220287345A1 (en) 2019-08-08 2022-09-15 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
DE102022003441A1 (de) 2022-09-17 2024-03-28 Jutta Ibrahim Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256162A (en) * 1968-08-16 1971-12-08 Braun Fa B Improvements in and relating to liquid products for intravenous administration
FR2215212B1 (de) * 1973-01-18 1976-03-05 Seperic Ch
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
GB2118437B (en) * 1982-03-01 1984-12-12 Efamol Ltd Composition for treating alcoholism
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
DE3229956A1 (de) * 1982-08-12 1984-02-16 Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf Arzneimittel mit cytostatischer wirkung
DE3514328C1 (de) * 1985-04-19 1986-09-11 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg Verwendung von L-Ornithin bei der selektiven Hemmung von cytotoxischen T-Lymphozyten-Effektorzellen
ATE88631T1 (de) * 1986-09-17 1993-05-15 Clintec Nutrition Co Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
EP0310639B1 (de) * 1987-02-20 1993-03-03 Shriners Hospitals For Crippled Children Omega-3-fettsäuren zur behandlung von traumatischen verwundungen
DE3726299A1 (de) * 1987-06-26 1989-02-23 Dietl Hans Fettemulsion zur intravenoesen anwendung

Also Published As

Publication number Publication date
CH678918A5 (de) 1991-11-29
BE1002890A3 (fr) 1991-07-16
GB2216418A (en) 1989-10-11
LU87471A1 (fr) 1990-10-02
NL8900574A (nl) 1989-10-02
CA1334576C (en) 1995-02-28
DE3907649A1 (de) 1989-09-28
KR890014103A (ko) 1989-10-21
FI891145A0 (fi) 1989-03-09
HU209973B (en) 1995-01-30
IT1229562B (it) 1991-09-04
IT8919704A0 (it) 1989-03-09
FI94591B (fi) 1995-06-30
GB8905385D0 (en) 1989-04-19
FR2628324A1 (fr) 1989-09-15
GB2216418B (en) 1991-12-11
SE8900828D0 (sv) 1989-03-09
HUT60432A (en) 1992-09-28
SE8900828L (sv) 1989-09-10
FI891145A (fi) 1989-09-10
FR2628324B1 (fr) 1994-05-27
JPH01316316A (ja) 1989-12-21
DE3907649C2 (de) 1996-07-11

Similar Documents

Publication Publication Date Title
FI94591C (fi) Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi
FI93949B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten suolayhdisteiden valmistamiseksi
JPH01121300A (ja) 乳汁に由来するポリペプチド成長因子
JP2009242413A (ja) アミノ酸をベースとする医薬
US5869714A (en) Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them
Ivanovska et al. Influence of cinnamic acid on lymphocyte proliferation, cytokine release and Klebsiella infection in mice
Nonnecke et al. Leucine and its catabolites alter mitogen-stimulated DNA synthesis by bovine lymphocytes
JP2000500447A (ja) 胸腺ホルモン由来のペプチド複合体、その医薬用途およびそれを含有する組成物
CN110650970A (zh) 抗菌肽及其药品
SE8406555D0 (sv) A process for obtaining ready-for-fertilization sexual products from sexually mature fish
ES2326091T3 (es) Composicion de aceite de pescado marino antivirica e inmunoestimulante.
US6469137B1 (en) Myelopeptides and their therapeutic use
ATE90874T1 (de) Verwendung von phytinsaeure als antidot gegen alkoholvergiftung.
Funk et al. Utilization of the L-and DL-isomers of α-keto-β-methylvaleric acid by rats and comparative efficacy of the keto analogs of branched-chain amino acids provided as ornithine, lysine and histidine salts
Ash et al. Impact of Nippostrongylus brasiliensis (Nematoda) on the serum albumin and amino acid concentrations of rats fed adequate or protein-deficient diets
KR100346334B1 (ko) 스코폴레틴으로 이루어진 염증 치료용 약제 조성물
FR2691153A1 (fr) Dodécapeptides monomère et dimère, utilisation en tant qu'agents anti-mégacaryocytaires.
KR20050119083A (ko) 슈퍼옥사이드 디스뮤타제 및 선택적인 5-리폭시게나아제저해제를 포함하는 조성물 및 그 적용 방법
JPH04330095A (ja) 生理活性ポリペプチド、その製造法および抗菌剤
WINITZ et al. Chemically Defined Diets

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: BIOREX KFT